Finally, although this set of genes was evaluated in a global population of male patients treated with ICIs, we aimed to study their presence in prostate cancer based on the nodal status (N0 vs. N1) and presence of the TMPRRS2-ERG fusion gene. The gene discussed is ERG; the disease is prostate carcinoma.